• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma,adjacent noncancerous tissues and urine

    2019-07-12 01:38:54JiaHaoLiangYanLinTingOuyangWanTangYaoHuangWeiYeJiaYunZhaoZheNingWangChangChunMa
    World Journal of Gastroenterology 2019年25期

    Jia-Hao Liang, Yan Lin, Ting Ouyang, Wan Tang, Yao Huang, Wei Ye, Jia-Yun Zhao, Zhe-Ning Wang,Chang-Chun Ma

    AbstractBACKGROUND Several studies have demonstrated a correlation between esophageal cancer (EC)and perturbed urinary metabolomic profiles, but none has described the correlation between urine metabolite profiles and those of the tumor and adjacent esophageal mucosa in the same patient.AIM To investigate how urinary metabolic phenotypes were linked to the changes in the biochemical landscape of esophageal tumors.METHODS Nuclear magnetic resonance-based metabolomics were applied to esophageal tumor tissues and adjacent normal mucosal tissues alongside patient-matched urine samples.RESULTS Analysis revealed that specific metabolite changes overlapped across both metrics, including glucose, glutamate, citrate, glycine, creatinine and taurine,indicating that the networks for metabolic pathway perturbations in EC,potentially involved in but not limited to disruption of fatty acid metabolism,glucose and glycolytic metabolism, tricarboxylic acid cycle and glutaminolysis.Additionally, changes in most urinary biomarkers correlated with changes in biomarker candidates in EC tissues, implying enhanced energy production for rapid cell proliferation.reviewed and approved by the Second Affiliated Hospital,Shantou University Medical College Review Board (2018-44).Informed consent statement:Informed consent was obtained from each subject prior to participation in this study.Conflict-of-interest statement: The authors declare that they have no competing interests related to this study.Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0)license, which permits others to distribute, remix, adapt, build upon this work non-commercially,and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:http://creativecommons.org/licen ses/by-nc/4.0/Manuscript source: Unsolicited manuscript Received: January 25, 2019 Peer-review started: January 25,2019 First decision: February 26, 2019 Revised: May 13, 2019 Accepted: May 31, 2019 Article in press: June 1, 2019 Published online: July 7, 2019 P-Reviewer: Hashimoto N, Luyer MDP S-Editor: Cui LJ L-Editor: Filipodia E-Editor: Ma YJ CONCLUSION Overall, these associations provide evidence for distinct metabolic signatures and pathway disturbances between the tumor tissues and urine of EC patients, and changes in urinary metabolic signature could reflect reprogramming of the aforementioned metabolic pathways in EC tissues. Further investigation is needed to validate these initial findings using larger samples and to establish the underlying mechanism of EC progression.

    Key words: Esophageal cancer; Metabolites; Metabolic pathways; Nuclear magnetic resonance-based metabolomics; Tumor tissue; Urine

    INTRODUCTION

    Esophageal cancer (EC) is the eighth most common type of malignant tumor and the sixth leading cause of cancer-related death worldwide[1]. Identifying cancer-related biomarkers of EC is essential for its diagnosis and therapeutic intervention in the early stage, which in turn will significantly increase patient survival. While there are a few diagnostic/screening techniques, such as upper gastrointestinal endoscopy, endoscopy-based balloon cytology, and serum carcinoembryonic antigen (commonly known as CEA) test, high-throughput and sensitive molecular tools are required to elucidate specific disease biomarkers for optimal disease management. Metabolomics,in which the global changes of small molecular weight metabolites in a given biological specimen are investigated, has considerable potential to identify useful biomarkers, thereby stratifying subjects into disease or nondiseased categories[2,3].Proton nuclear magnetic resonance (1H-NMR) spectroscopy is a well-established,robust, noninvasive and reproducible method for quantifying metabolic profiles[4],and it has several advantages over other analytical techniques, such as liquid chromatography mass spectroscopy and gas chromatography mass spectroscopy,including nondestructive analysis of samples, minimal sample preparation, and the ability to detect multiple metabolites within a single experiment[5-8]. NMR data combined with multivariate statistical analysis, such as orthogonal partial least squares discriminant analysis (OPLS-DA), which can be utilized for disease cla-ssification(through the use of score plots) and biomarker detection (through the use of loading plots), allow for the identification of potential biomarkers in biological specimens and improve the ability to identify specific metabolic pathways and networks associated with the disease process.

    Urine is a biological fluid commonly used by NMR-based metabolomics[9,10]because it is easily collected in large volumes with noninvasive procedures and may provide substantial diagnostic information for many cancer types[7,11-13]. Biomarkers in urine may be derived from cell apoptosis, glomerular filtration of blood plasma, cell sloughing, epithelial cell secretion of exosomes, and other processes[14]. Several NMR spectroscopy-based metabolomic studies have reported that metabolite compositions of urine samples from EC patients differ from those of healthy controls (HCs)[15,16].However, little is known about the systemic mechanistic link between esophageal tissues and urine, owing to the invasiveness of tissue sampling and sensitivity of the urinary metabolome to factors such as environment, food and genetic composition.

    The aim of this research was to profile parallel metabolites of EC tissues and adjacent noncancerous tissues alongside urine samples from the same patients, to investigate how urinary metabolomic phenotypes associate with tumor tissue, and to identify specific disturbed metabolic pathways in esophageal tissues and urine. Such information would be vital to bridge the gap between the systemic metabolic characteristics of EC tissues and the corresponding samples of urine and may help advance the utility of urinary-based metabolites as relevant indicators of EC tissue microenvironment.

    MATERIALS AND METHODS

    Patient recruitment and sample collection

    This study was approved by the Ethics Committee of Shantou University Medical College. Written informed consent was obtained from each subject prior to participation. Early-morning midstream urine samples were collected preoperatively from 41 EC patients and 40 HCs between August 2015 and October 2016 at the Second Affiliated Hospital of Shantou University Medical College. EC patients were diagnosed by microscopy, biopsy, or surgical resection, and the disease stage was determined according to the American Joint Committee on Cancer (AJCC) staging system for esophageal tumors: Stage I/II, 15 patients; stage III, 11 patients; stage IV,15 patients. Each urine sample was mixed with 50 μL sodium azide preservative and stored at -80 °C until further analysis. Patient-matched EC tissues and their corresponding adjacent noncancerous tissues (~5 cm away from the tumor margin) were collected from 20 EC patients and immediately stored at -80 °C until NMR analysis.Exclusion criteria for all participants included use of antibiotics, nonsteroidal antiinflammatory drugs, statins, or probiotics within 2 mo of study participation.Additional exclusion criteria for EC patients included chemotherapy or radiotherapy prior to surgery. The demographic and clinical characteristics of the EC patients and con-trols are summarized in Table 1.

    Urine sample preparation

    Frozen urine samples were thawed at room temperature and mixed to suspend any settled precipitate. After adding 300 μL PBS/D2O buffer (0.1 M, pH 7.4) to 600 μL of each urine sample, the mixture was homogenized by vortexing for 60 s and then centrifuged at 8000 rpm for 10 min. Subsequently, a volume of 500 μL of the supernatant was transferred into an Eppendorf vial, to which 50 μL of a stock solution of sodium (3-trimethylsilyl)-2, 2, 3, 3-tetradeuteriopropionate (TSP)/D2O was added,using a chemical shift reference (0.0 ppm) for spectral alignment. Finally, the resulting mixture was centrifuged at 10000 rpm for 5 min, and 500 μL of the prepared sample was transferred into a 5-mm high-resolution NMR tube for1H-NMR analysis.

    Tissue sample preparation

    The frozen tissue samples weighed ~300 mg and were thawed and cut into small pieces at room temperature. After adding 1.8 mL mixture containing 0.6 mL distilled water (2 mL/g tissue) and 1.2 mL methanol (4 mL/g tissue), the resulting mixture was homogenized at 16000 rpm for 80 s. After homogenization, the mixture was added to chloroform (4 mL/g tissue) and distilled water (4 mL/g tissue) and vortexed for 60 s. The suspension was then left on ice for 15 min and centrifuged at 2000 rpm for 5 min to facilitate separation of the liquid layers. The resulting supernatant was evaporated under a stream of nitrogen and then dried under vacuum for a minimum of 18 h. Subsequently, the lyophilized powder was redissolved with 550 μL PBS/D2O buffer (0.1 mol/L, pH 7.4), to which 50 μL of a stock solution of TSP/D2O was added.After homogenization and centrifugation at 10000 rpm for 5 min, 500 μL supernatant was transferred into a 5-mm high-resolution NMR tube for1H-NMR analysis.

    1H-NMR analysis

    All samples were detected by a Bruker AVII 400 MHz NMR spectrometer (Bruker Biospin, Germany) operating at a1H frequency of 400.13 MHz. Magnetic field homogeneity was optimized by gradient or manual shimming prior to acquisition.The temperature was maintained at 298 K and lock performed on the D2O signal.1H NMR spectra of urine samples were obtained using a 1D nuclear Overhauser enhancement spectroscopy pulse sequence [RD-90°-t1-90°-tm-90°- ACQ], with the following acquisition parameters: Recycle delay (RD) 1.5 s; t1 3 μs; mixing time, tm 100 ms; 90° pulse width 7.3 μs; number of scans (NS) 256; number of points, TD 32768;spectral width (SW) 8012.82 Hz; acquisition time (AQ) 2.04 s. Water suppression was achieved by irradiation of the water peak during RD and tm. Esophageal tissue1H NMR spectra were recorded using a standard (1D) Carr-Purcell-Meiboom-Gill pulse sequence with the following acquisition parameters: number of dummy scans 4; RD 70 ms; 90° pulse width 10 μs; NS 64; TD 65536; SW 8012 Hz; AQ 4.09 s.

    Table 1 Summary of clinical and demographic features for study subjects and tumor characteristics

    1H NMR spectral data processing

    All free induction decays from 1D1H-NMR of the tissues and urine samples were multiplied by a 0.3 Hz exponential line broadening prior to Fourier transformation.1H-NMR spectra were then corrected for phase and baseline distortion and calibrated to TSP at 0.0 ppm by using MestReNova software (version 8.1.0, Mestrelab Research,Santiagode Compostella, Spain). To reduce the complexity of the NMR data, the spectral range from 0.8 to 9.0 ppm was segmented into buckets with the equal width of 0.004 ppm. The region of 5.5-4.5 ppm was discarded to eliminate imperfect water suppression. Each bucket was internally normalized to the total integral of the spectrum prior to pattern recognition analysis, to eliminate the dilution or bulk mass differences among samples due to the different sample weight.

    Pattern recognition analysis and cross validation

    To maximize class discrimination between EC patient and HC urine samples, as well as between EC tissues and their corresponding noncancerous tissues, multivariate data analysis was applied to the1H-NMR spectral data according to previously published and accepted methods[6,7]. The normalized NMR spectral data sets were unit variance scaled and analyzed using the SIMCA-P+ program (version 14.1, Umetrics AB; Umea, Sweden). OPLS-DA was applied to the analysis of1H-NMR spectral data to optimize the separation between experimental groups. The model quality was evaluated with the R2Y and Q2values, reflecting the explained fraction of variance and the model predictability. R2Y scores ranged between 0 and 1 and Q2scores between negative and 1, where a R2Y score of 1 demonstrated that the model explained 100% of variance, and a Q2score closer to 1 indicated higher reliability of the prediction in the cross-validation procedure. Validation of the OPLS-DA model was also performed by means of a permutation test (400 times). The R2Y in the permutated plot described

    how well the data fitted with the derived model, whereas Q2described the predictive ability of the derived model (Q2> 0.5 considered as good and Q2> 0.9 as excellent). To further evaluate the predictive power of the robust OPLS-DA model, 80% of samples were applied to construct a model, which was used to predict the remaining 20% of samples. The variable importance in the projection (VIP) values of all peaks from OPLS-DA models was taken as a coefficient for peak selection. The VIP value was represented by a unitless number, where higher values suggested greater discriminatory power of the metabolite. Those variables with VIP > 1 were considered potential biomarker candidates for group discrimination.

    Statistical analysis

    The relative concentrations of those metabolites with VIP > 1 were calculated by integrating the signals in the spectra. Statistical significance was assessed using the Mann-Whitney U test, and P < 0.05 was considered statistically significant. The relative concentrations of those metabolites with VIP > 1 were calculated by integrating the signals in the spectra, and data are presented as the mean fold difference in EC metabolite abundance compared to controls. To further evaluate the diagnostic power of the potential biomarkers whose levels significantly differed between experimental groups, receiver operating characteristic (ROC) analysis in SPSS version 16.0 was performed, and the optimal area under the ROC curve(AUROC), specificity and sensitivity of the metabolites were calculated, where AUROC > 0.8 indicated excellent diagnostic ability. Pearson correlation analysis was used to assess the association of biomarker candidates between urine and tumor tissues of EC patients with an OPLS-DA model using a correlation coefficient cut-off of |r| and correlation significance of P < 0.05. Correlation coefficients ranged from 1.0(maximum positive correlation) to -1.0 (maximum anticorrelation), with a value of 0 representing no correlation. Correspondingly, |r| > 0.44 (calculated for the sample size of 20) was considered to be a statistically significant relationship between the two metabolites.

    All right, said the fox, only don t be in such a hurry; let s wait till night, when the little birds have gone to roost, then I ll climb up and catch them all for you

    RESULTS

    Metabolic profiles of esophageal tissues and urine samples

    Representative 1D1H-NMR spectra of urine specimens acquired from EC patients,HCs and patient-matched esophageal tissue extracts are shown in Figure 1A and B.The standard 1D spectrum gave an overview of all metabolites. The major metabolites in the spectra were identified according to previous studies[17,18]and the Human Metabolome Database (http://www.hmdb.ca/). In all urine and esophageal tissue spectra, the aliphatic region at 0.8-4.2 ppm included numerous signals from the following water-soluble metabolites: Glutamate, glutamine, acetoacetate, citrate,cisaconitate, choline, creatine, creatinine and glycine, which are known to be involved in many biochemical processes, especially in energy metabolism.

    Good discrimination between EC patients and HCs was achieved by an OPLS-DA scores plot generated from1H-NMR spectra of urine specimens (Figure 2A-a). The predictive ability of the model was calculated by internal validation (R2Y = 0.902, Q2=0.682, CV-ANONA P < 0.01), suggesting that the model possessed a satisfactory fit with good predictive power. In order to evaluate the robustness of the OPLS-DA model described above, a random permutation test was performed 400 times to further evaluate the robustness of this model, as exhibited by the steep R2and Q2regression lines and difference between R2and Q2(R2Y = 0.886 and Q2= 0.660),indicating that this was an excellent model suitable for data analysis (Figure 2A-b). To further assess the predictive ability of the model for unknown samples, we randomly selected 80% of urine samples (“training set”, 33 EC patients and 32 HCs) to construct an OPLS-DA model, which was then used to predict the remaining 20% of samples(“testing set”, 8 EC patients and 8 HCs). As can be seen in Figure 2A-c, the testing sets of EC patients and HCs were correctly located in their corresponding region of the training sets. Urine metabolites that met the following conditions were considered potential metabolite biomarkers for EC detection: Levels of metabolites with VIP > 1 and the presence of a significant difference (P < 0.01) between metabolite levels of EC patients and HCs according to the Mann-Whitney U test. A total of ten urine metabolites were found to be significantly changed in EC patients compared to HCs (Table 2), including higher levels of acetoacetate, cis-aconitate, citrate and glutamate,together with lower amounts of glycine, taurine, creatinine, ethanolamine, glucose and hippurate.

    Tissue profiles from EC tumor tissues and their corresponding adjacent noncancerous tissues were clearly separated using the OPLS-DA scores plot (Figure 2B-a). Model parameters of the 400 times permutation test generated R2Y = 0.908 and Q2= 0.842 (Figure 2B-b). Moreover, the OPLS-DA model showed good performance for predicting the unknown samples (Figure 2B-c). Using these criteria (VIP > 1 and P< 0.05), the 15 metabolites listed in Table 3 were found to be significantly changed in EC tissues compared to their corresponding noncancerous tissues, including elevated levels of valine, leucine, alanine, acetate, citrate, succinate, choline and glutamate, as well as depleted levels of creatinine and creatine, glycine, threonine, taurine, glucose,and glutamine.

    Figure 1 Proton nuclear magnetic resonance spectra. A: 400 MHz representative urine proton nuclear magnetic resonance (1H-NMR) spectra obtained from esophageal cancer (EC) patient (a) and healthy control (b); B: Tissue 1H-NMR spectra obtained from EC tissue (c) and adjacent noncancerous tissue (d) referenced to tetradeuteriopropionate (0.0 ppm).

    Metabolic changes that overlap across urine and EC tissues

    Our parallel investigations revealed a few distinct and overlapping discriminatory metabolites between cancer tissues and urine of EC patients, including decreased levels of glucose, glycine, creatinine and taurine, together with increased levels of glutamate and citrate, as compared to their respective controls. Metabolic profiling associations between potential urine and tissue biomarkers were further analyzed,plotted as correlation heat maps color-coded by the strength of Spearman correlation coefficients (Figure 3). Changes in most potential urinary biomarkers (except for glutamate, citrate and glucose) were found to be correlated with changes in most biomarker candidates in EC tissues (except for glycine and acetate) (|r| > 0.44, P <0.05).

    Comparison of diagnostic performance of potential urinary biomarkers for

    Table 2 Potential urine biomarkers for discriminating esophageal cancer patients from healthy controls

    distinguishing EC

    Given that urinary glutamate, citrate and glucose in EC patients did not show correlation with esophageal tissue biomarkers, a panel of urinary metabolite markers composed of acetoacetate, cis-aconitate, hippurate, ethanolamine, glycine, creatinine and taurine was selected to compare their diagnostic performance for distinguishing EC patients from HCs. ROC analysis of the comparison of single urinary biomarkers and their combination showed that combined metabolites of the aforementioned metabolites had better diagnostic performance than any single metabolite alone in discriminating EC patients from HCs, with sensitivity, specificity and area under the curve values of 92.68%, 92.50% and 0.971, respectively (Figure 4).

    DISCUSSION

    The current study performed parallel investigations of EC tissues and adjacent noncancerous mucosal tissues alongside patient-matched urine samples to investigate how changes of the urine metabolome were linked to the changes of EC tissues metabolic phenotypes. Our study showed significant metabolic alterations in both urine and tumor tissues of EC patients compared to their respective HCs. Correlative analysis of the altered metabolites across both matrices revealed a few distinct and overlapping discriminatory metabolites, such as glucose, glycine, creatinine and taurine (decreased levels) together with glutamate and citrate (increased amounts),suggesting that EC is associated with the following dysregulated metabolic pathway perturbations, including but not limited to fatty acid metabolism, glucose and glycolytic activity, tricarboxylic acid (TCA) cycle and glutaminolysis. Metabolic profiling correlations between esophageal tissues and urine showed that most potential urine biomarkers were correlated with most of the discriminating metabolites in EC tissues, indicating that changes in urine metabolic signature could reflect reprogramming of metabolic pathways in tumor tissues, highlighting the significance of the distinct urinary metabolic profiles as potential novel and nonin-vasive indicators for EC detection.

    Figure 2 Pattern recognitions. A: Pattern recognition of urine metabolomic profiles analyzed by proton nuclear magnetic resonance (1H-NMR) spectroscopy. (a)orthogonal partial least squares discriminant analysis (OPLS-DA) scatter plot of urine samples based on esophageal cancer (EC) patients (green dots) and healthy controls (HCs) (blue squares); (b) Statistical validation of the corresponding OPLS-DA model by permutation analysis (400 times); (c) Score plots of OPLS-DA prediction model. 80% of samples were applied to construct the model, which was used to predict the remaining 20% of samples [testing set, 8 HCs (gold diamonds);8 EC patients (red triangles)]; B: Pattern recognition of tissue metabolomic profiles analyzed by 1H-NMR spectroscopy. (a) OPLS-DA scatter plot of EC tissue samples obtained (purple inverted triangles) and adjacent noncancerous tissue (orange pentagons); (b) Statistical validation of the corresponding OPLS-DA model by permutation analysis (400 times); (c) Score plots of OPLS-DA prediction model, with 80% of the samples applied to construct the model, which was used to predict the remaining 20% of samples [testing set, 4 EC tissues (green hexagons); 4 adjacent non-cancerous tissues (blue crosses)].

    Table 3 Potential tissue biomarkers for discriminating esophageal cancer tissue from adjacent noncancerous tissue

    In addition to specific metabolite differences between tumor tissues and urine in EC patients and HCs, we also evaluated the relationships between the metabolic networks in both tissues and urine. Decreased metabolite levels of glucose, glycine,creatinine and taurine, as well as increased citrate and glutamate in EC tissues, were also detectable in the urine of EC patients. These distinct and overlapping metabolites may reflect tumor cell shedding and represent metabolic pathway aberrations across both matrices. This potentially reveals linkages to disturbances of fatty acid metabolism, glucose and glycolytic activity, TCA cycle and glutaminolysis associated with tumor proliferation. Correlative analysis of metabolic profiling between EC tissues and urine showed that changes in most potential urinary biomarkers were correlated with changes in most biomarker candidates in EC tissues, implying enhanced energy production required for rapid cell proliferation. Creatinine was found to be the most sensitive predictor of EC in urine metabolite, with an AUC of 0.790. Overall, these associations provide evidence of distinct metabolic signatures and pathway disturbances across both matrices, and changes in urinary metabolic signature could reflect the EC tissue microenvironment.

    In conclusion, our parallel investigations of EC patients through1H-NMR metabolomics revealed a great number of altered metabolites and metabolic pathway networks in EC patient urine and tumor tissues compared with HCs. We identified a few overlapping discriminatory metabolites across both matrices, derived from fatty acid metabolism (taurine and glycine), as well as metabolites (e.g., glucose, glutamate,citrate and creatinine) involved in glucose and glycolytic metabolism, the TCA cycle and glutaminolysis. Correlative analysis of metabolic profiling across tumor tissues and urine in EC patients showed that changes in most potential urinary biomarkers were correlated with changes in most candidate biomarkers in EC tissues, implying enhanced energy production required for rapid cell proliferation. In summary, these associations provide clear evidence of different metabolic signatures and metabolic pathway disturbances between EC tissues and urine, and changes in urinary metabolic signatures could reflect the EC tissue microenvironment. Our study highlighted the significance of the distinct urinary metabolic profile as a potential noninvasive indicator of EC detection. Further investigation is needed to validate these initial findings using larger samples and to establish the mechanism underlying EC progression.

    ACKNOWLEDGMENTS

    The authors thank Ju-Rong Yang for kindly providing us with the NMR experimental setting and Dr. Hong-Jun Luo for handling of tissue samples.

    Figure 4 Comparison of single and combined metabolites receiver operating characteristic curves for distinguishing esophageal cancer patients from healthy controls.

    Figure 5 Altered metabolic pathways for the most relevant distinguishing metabolites (potential biomarkers) in urine and tissue samples between esophageal cancer patients and healthy controls. Red text: Increased with respect to control in both esophageal cancer (EC) patient tissue and urine; pink text:Increased with respect to control in EC tissue; orange text: Increased with respect to control in EC patient urine; purple text: Decreased with respect to control in both EC patient tissue and urine; blue text: Decreased with respect to control in EC tissue; green text: Decreased with respect to control in EC patient urine.

    ARTICLE HIGHLIGHTS

    Research background

    A large number of studies have revealed changes of urinary metabolites between esophageal cancer (EC) and healthy controls (HCs), and some studies have demonstrated a correlation between EC and perturbed urinary metabolomic profiles.

    Research motivation

    However, none of the previous studies has described the correlation between urine metabolite profiles and those of the tumor and adjacent colonic mucosa in the same patient. Our study revealed a significant number of altered metabolites and metabolic pathway networks in EC patient urine and tumor tissues compared with HCs.

    Research objectives

    Our work is the first parallel investigation of esophageal tumor tissues and adjacent normal mucosal tissues alongside patient-matched urine samples to investigate how urinary metabolic phenotypes were linked to changes in the biochemical landscape of esophageal tumors.

    Research methods

    All samples were detected by a Bruker AVII 400 MHz nuclear magnetic resonance spectrometer,and all spectral data were applied to pattern recognition analysis and cross-validation by SIMCA-P software. Then, statistical significance was assessed using the Mann-Whitney U test and receiver operating characteristic analysis to calculate biomarker metabolites. Finally, we employed Pearson Correlation Analysis to assess the associations of biomarker candidates between urine and tumor tissues of EC patients.

    Research results

    Our study revealed metabolite changes that overlapped across both metrics, including glucose,glutamate, citrate, glycine, creatinine and taurine, indicating the networks for metabolic pathway perturbations in EC. Additionally, changes in most urinary biomarkers were correlated with changes in biomarker candidates in EC tissues.

    Research conclusions

    Our research is the first parallel investigation to investigate how urinary metabolic phenotypes were linked to the changes in the biochemical landscape of esophageal tumors. Our study showed significant metabolic alterations in both urine and tumor tissues of EC patients compared to their respective HCs. Our research revealed a few distinct and overlapping discriminatory metabolites, suggesting that EC is associated with the following dysregulated metabolic pathway perturbations. Furthermore, the metabolic profiling correlations between esophageal tissues and urine showed that most urine potential biomarkers were correlated with most of the discriminating metabolites in EC tissues, indicating that changes in the urine metabolic signature could reflect reprogramming of metabolic pathways in tumor tissue, highlighting the significance of the distinct urinary metabolic profiles as potential novel and noninvasive indicators for EC detection.

    Research perspectives

    With experiences in our study, we realized that many metabolites have associations in samples of cancer patients. In our same group, we are now investigating the serum samples of EC patients to see whether the same pattern of serum levels of amino acids can be found in EC patients.

    久久久久久亚洲精品国产蜜桃av| 国产精品九九99| 久久99热这里只频精品6学生| 如日韩欧美国产精品一区二区三区| 热99久久久久精品小说推荐| 在线观看人妻少妇| 动漫黄色视频在线观看| 下体分泌物呈黄色| 午夜福利视频精品| 国产日韩一区二区三区精品不卡| 一二三四在线观看免费中文在| www.自偷自拍.com| 五月开心婷婷网| 国产色视频综合| 熟女少妇亚洲综合色aaa.| 成人18禁高潮啪啪吃奶动态图| 日韩大片免费观看网站| 国产成人精品无人区| 日本黄色日本黄色录像| 久久精品亚洲熟妇少妇任你| 国产99久久九九免费精品| 欧美 亚洲 国产 日韩一| 麻豆乱淫一区二区| a级毛片黄视频| 中文字幕av电影在线播放| 国产成人欧美在线观看 | 精品乱码久久久久久99久播| 黄片小视频在线播放| 人成视频在线观看免费观看| 日韩有码中文字幕| e午夜精品久久久久久久| 欧美日韩成人在线一区二区| 色94色欧美一区二区| 午夜福利一区二区在线看| 男女午夜视频在线观看| 国产日韩欧美亚洲二区| 亚洲少妇的诱惑av| 国产亚洲av高清不卡| 淫妇啪啪啪对白视频| 久久这里只有精品19| 免费看十八禁软件| 亚洲一码二码三码区别大吗| 满18在线观看网站| 99久久国产精品久久久| 久久青草综合色| 热re99久久精品国产66热6| 新久久久久国产一级毛片| 国产欧美日韩一区二区三区在线| 国产欧美日韩一区二区精品| 亚洲av国产av综合av卡| 亚洲一区二区三区欧美精品| 中文欧美无线码| 熟女少妇亚洲综合色aaa.| 啦啦啦视频在线资源免费观看| 久久久久久久久免费视频了| 欧美黄色淫秽网站| 别揉我奶头~嗯~啊~动态视频| 免费观看a级毛片全部| 国产成人一区二区三区免费视频网站| 久久精品国产99精品国产亚洲性色 | 777久久人妻少妇嫩草av网站| 看免费av毛片| 正在播放国产对白刺激| 欧美精品av麻豆av| 五月天丁香电影| 国产精品久久久av美女十八| 大型av网站在线播放| 精品欧美一区二区三区在线| 高清欧美精品videossex| 亚洲成人免费av在线播放| 国内毛片毛片毛片毛片毛片| 精品久久蜜臀av无| 变态另类成人亚洲欧美熟女 | 日韩有码中文字幕| 久久这里只有精品19| 国产精品 国内视频| 精品国产乱码久久久久久男人| 国产成人精品无人区| av网站免费在线观看视频| 日本wwww免费看| 9191精品国产免费久久| 国产在线观看jvid| 老鸭窝网址在线观看| 免费av中文字幕在线| 老司机在亚洲福利影院| 亚洲,欧美精品.| 超色免费av| 成人影院久久| 亚洲全国av大片| 成人亚洲精品一区在线观看| 2018国产大陆天天弄谢| 少妇 在线观看| 久久久国产欧美日韩av| 亚洲精品久久成人aⅴ小说| 丁香六月天网| 亚洲国产成人一精品久久久| 蜜桃国产av成人99| 女人高潮潮喷娇喘18禁视频| 十八禁高潮呻吟视频| 国产精品久久久av美女十八| 欧美亚洲 丝袜 人妻 在线| 欧美精品av麻豆av| 18禁观看日本| 精品福利永久在线观看| 亚洲精品国产色婷婷电影| 亚洲欧美精品综合一区二区三区| 人人妻,人人澡人人爽秒播| 考比视频在线观看| 国产欧美亚洲国产| 亚洲人成77777在线视频| 国产在线视频一区二区| kizo精华| 精品人妻熟女毛片av久久网站| 久久久国产精品麻豆| 久久精品成人免费网站| 久久99热这里只频精品6学生| 999久久久国产精品视频| 国产精品自产拍在线观看55亚洲 | 日本av手机在线免费观看| 婷婷成人精品国产| 人人妻人人澡人人爽人人夜夜| 精品久久久久久久毛片微露脸| av超薄肉色丝袜交足视频| 久久精品国产亚洲av高清一级| 天天操日日干夜夜撸| 天天操日日干夜夜撸| 国产av又大| 99热网站在线观看| 夫妻午夜视频| 欧美日韩国产mv在线观看视频| 91字幕亚洲| 99精国产麻豆久久婷婷| 丰满迷人的少妇在线观看| 999精品在线视频| 十八禁网站免费在线| 99riav亚洲国产免费| 婷婷丁香在线五月| 成年女人毛片免费观看观看9 | 80岁老熟妇乱子伦牲交| 亚洲,欧美精品.| 亚洲av日韩在线播放| 久久久久网色| 99re6热这里在线精品视频| 国产极品粉嫩免费观看在线| 午夜91福利影院| 欧美精品高潮呻吟av久久| 国产精品 国内视频| 久久人妻av系列| 国产精品免费视频内射| 欧美av亚洲av综合av国产av| 欧美激情极品国产一区二区三区| 少妇裸体淫交视频免费看高清 | 国产精品久久久久久精品古装| 久久久久久久国产电影| 男女免费视频国产| 中文字幕av电影在线播放| 波多野结衣av一区二区av| 肉色欧美久久久久久久蜜桃| 精品国产乱子伦一区二区三区| 男人舔女人的私密视频| 久久九九热精品免费| √禁漫天堂资源中文www| 国产亚洲一区二区精品| 国产一卡二卡三卡精品| 大型av网站在线播放| 成人手机av| 制服诱惑二区| 夜夜夜夜夜久久久久| 妹子高潮喷水视频| 亚洲 国产 在线| 午夜福利欧美成人| 90打野战视频偷拍视频| 在线看a的网站| 首页视频小说图片口味搜索| 亚洲精品成人av观看孕妇| 岛国毛片在线播放| 亚洲第一欧美日韩一区二区三区 | 999久久久国产精品视频| 精品一品国产午夜福利视频| 国产伦理片在线播放av一区| 久久国产精品大桥未久av| 国产精品偷伦视频观看了| 人妻久久中文字幕网| 黄色毛片三级朝国网站| 97人妻天天添夜夜摸| 精品国产一区二区三区四区第35| 亚洲精华国产精华精| 久久午夜综合久久蜜桃| 亚洲精品成人av观看孕妇| 欧美激情 高清一区二区三区| 一进一出抽搐动态| 黑人操中国人逼视频| 高清av免费在线| 国产一区二区在线观看av| 一级毛片女人18水好多| 18禁观看日本| 黑丝袜美女国产一区| 午夜精品久久久久久毛片777| www.熟女人妻精品国产| 岛国在线观看网站| 中文字幕制服av| 一区福利在线观看| 成人亚洲精品一区在线观看| 成年人黄色毛片网站| 中文字幕av电影在线播放| 午夜福利欧美成人| 色婷婷av一区二区三区视频| 久久婷婷成人综合色麻豆| 男女之事视频高清在线观看| 国产精品电影一区二区三区 | 日韩欧美三级三区| 亚洲综合色网址| 欧美日韩黄片免| 丝袜美腿诱惑在线| 免费一级毛片在线播放高清视频 | 窝窝影院91人妻| 亚洲第一av免费看| 精品久久久久久电影网| 999久久久精品免费观看国产| 免费观看人在逋| 我的亚洲天堂| 91麻豆精品激情在线观看国产 | 国产国语露脸激情在线看| 亚洲色图av天堂| 国产精品.久久久| 国产精品久久电影中文字幕 | 两个人免费观看高清视频| 热99re8久久精品国产| 97人妻天天添夜夜摸| 人人妻人人澡人人爽人人夜夜| 高清在线国产一区| 精品国产一区二区三区四区第35| 免费不卡黄色视频| 午夜精品国产一区二区电影| 汤姆久久久久久久影院中文字幕| 下体分泌物呈黄色| 18禁美女被吸乳视频| 久久青草综合色| 午夜福利乱码中文字幕| 大码成人一级视频| 亚洲伊人色综图| 丝袜人妻中文字幕| 岛国在线观看网站| 国产伦人伦偷精品视频| 美女福利国产在线| 亚洲成av片中文字幕在线观看| 成人三级做爰电影| 精品亚洲成国产av| 日本一区二区免费在线视频| 女同久久另类99精品国产91| 女人久久www免费人成看片| 少妇的丰满在线观看| 蜜桃国产av成人99| 桃红色精品国产亚洲av| 精品福利观看| 久久人妻熟女aⅴ| 一级毛片精品| 亚洲精品美女久久久久99蜜臀| 欧美日韩亚洲国产一区二区在线观看 | 午夜激情av网站| 天天添夜夜摸| 国精品久久久久久国模美| 午夜福利一区二区在线看| 成人国产av品久久久| 天天操日日干夜夜撸| 精品少妇久久久久久888优播| 亚洲国产看品久久| 大码成人一级视频| 少妇精品久久久久久久| 亚洲国产av影院在线观看| 国产亚洲一区二区精品| 日韩大码丰满熟妇| 777久久人妻少妇嫩草av网站| 国产精品av久久久久免费| 青青草视频在线视频观看| avwww免费| 精品一区二区三区四区五区乱码| 12—13女人毛片做爰片一| 啪啪无遮挡十八禁网站| a级毛片黄视频| 亚洲性夜色夜夜综合| 人人妻人人添人人爽欧美一区卜| 欧美午夜高清在线| 午夜久久久在线观看| 丁香六月天网| 桃花免费在线播放| 亚洲av成人不卡在线观看播放网| 女警被强在线播放| 午夜精品国产一区二区电影| 最黄视频免费看| 成人特级黄色片久久久久久久 | 国产亚洲精品一区二区www | 夜夜夜夜夜久久久久| 美女视频免费永久观看网站| 大香蕉久久成人网| 黄网站色视频无遮挡免费观看| 日本a在线网址| 亚洲av成人一区二区三| 女人久久www免费人成看片| 人人澡人人妻人| 考比视频在线观看| 午夜久久久在线观看| 天天躁狠狠躁夜夜躁狠狠躁| 极品人妻少妇av视频| 久久久久久人人人人人| 精品熟女少妇八av免费久了| 老熟妇仑乱视频hdxx| 又大又爽又粗| 国产日韩欧美视频二区| 亚洲人成电影观看| 侵犯人妻中文字幕一二三四区| 男女免费视频国产| 久久久久网色| 精品福利永久在线观看| 777久久人妻少妇嫩草av网站| 国产伦人伦偷精品视频| 老司机深夜福利视频在线观看| 日韩熟女老妇一区二区性免费视频| 高潮久久久久久久久久久不卡| 日韩欧美一区视频在线观看| 午夜久久久在线观看| 在线观看一区二区三区激情| 日韩大片免费观看网站| 少妇精品久久久久久久| 大码成人一级视频| 午夜福利欧美成人| 午夜久久久在线观看| 欧美在线黄色| 国产男女内射视频| 人妻 亚洲 视频| av网站在线播放免费| videos熟女内射| 99久久国产精品久久久| 午夜精品国产一区二区电影| 国产成人av教育| 国产成人欧美| 日韩有码中文字幕| 黑人巨大精品欧美一区二区蜜桃| 国产成人av教育| 日韩免费av在线播放| 久久香蕉激情| 欧美日韩黄片免| 久久精品亚洲av国产电影网| 日韩中文字幕欧美一区二区| 欧美日韩成人在线一区二区| 久久久精品区二区三区| 成人手机av| 国产亚洲一区二区精品| 亚洲色图 男人天堂 中文字幕| 一级黄色大片毛片| 久久精品91无色码中文字幕| 亚洲欧美激情在线| 国产黄色免费在线视频| 一边摸一边做爽爽视频免费| 欧美乱妇无乱码| 中文亚洲av片在线观看爽 | 国产aⅴ精品一区二区三区波| 欧美变态另类bdsm刘玥| 2018国产大陆天天弄谢| 少妇被粗大的猛进出69影院| 精品第一国产精品| 深夜精品福利| 丁香六月欧美| 国产免费现黄频在线看| 色播在线永久视频| 91av网站免费观看| 国产精品国产高清国产av | 免费av中文字幕在线| 日韩欧美一区视频在线观看| av天堂久久9| 国产精品免费一区二区三区在线 | 在线观看舔阴道视频| 成在线人永久免费视频| 欧美乱码精品一区二区三区| 久久精品国产亚洲av高清一级| 757午夜福利合集在线观看| 日本a在线网址| www日本在线高清视频| 亚洲精品中文字幕一二三四区 | 香蕉国产在线看| 婷婷成人精品国产| 人人妻人人澡人人看| 亚洲av成人不卡在线观看播放网| 成人国产av品久久久| 精品欧美一区二区三区在线| 国产高清激情床上av| 色尼玛亚洲综合影院| 午夜福利乱码中文字幕| 丰满迷人的少妇在线观看| 99精品欧美一区二区三区四区| 亚洲欧美日韩高清在线视频 | www日本在线高清视频| 大型av网站在线播放| 97人妻天天添夜夜摸| 亚洲精品自拍成人| 日本黄色视频三级网站网址 | 丁香六月欧美| 俄罗斯特黄特色一大片| 免费在线观看视频国产中文字幕亚洲| 一级片免费观看大全| 国产精品一区二区精品视频观看| 久久精品亚洲av国产电影网| 久久久久久久国产电影| 成人国产av品久久久| 欧美日韩亚洲国产一区二区在线观看 | 国产日韩欧美亚洲二区| 成人三级做爰电影| 国产一卡二卡三卡精品| 啦啦啦中文免费视频观看日本| 黄色视频不卡| 天天躁日日躁夜夜躁夜夜| 精品免费久久久久久久清纯 | 一区福利在线观看| 最近最新中文字幕大全电影3 | 高清黄色对白视频在线免费看| 老司机在亚洲福利影院| 国产黄频视频在线观看| 亚洲 国产 在线| 国产区一区二久久| 精品国产一区二区三区四区第35| av天堂久久9| 亚洲精品美女久久久久99蜜臀| 国产成人免费无遮挡视频| 国产免费现黄频在线看| 在线十欧美十亚洲十日本专区| www.999成人在线观看| 中文字幕av电影在线播放| 免费高清在线观看日韩| 99国产精品一区二区三区| 精品福利永久在线观看| 另类精品久久| 三级毛片av免费| 日韩成人在线观看一区二区三区| 亚洲精品国产一区二区精华液| 亚洲视频免费观看视频| xxxhd国产人妻xxx| 久久中文字幕人妻熟女| 美女国产高潮福利片在线看| 99riav亚洲国产免费| 飞空精品影院首页| 日韩一卡2卡3卡4卡2021年| 亚洲第一av免费看| 欧美大码av| 十八禁网站免费在线| 大片免费播放器 马上看| 51午夜福利影视在线观看| 一级a爱视频在线免费观看| 成年人黄色毛片网站| 亚洲 国产 在线| 久久精品国产99精品国产亚洲性色 | 国产av精品麻豆| 无限看片的www在线观看| 一二三四社区在线视频社区8| 久久午夜综合久久蜜桃| 亚洲av日韩精品久久久久久密| 中文字幕精品免费在线观看视频| 视频在线观看一区二区三区| 国产成人欧美| 亚洲成国产人片在线观看| av欧美777| 制服人妻中文乱码| 国产亚洲欧美在线一区二区| 免费日韩欧美在线观看| 嫁个100分男人电影在线观看| 亚洲国产欧美日韩在线播放| 一本—道久久a久久精品蜜桃钙片| 亚洲精品久久成人aⅴ小说| 精品一区二区三区av网在线观看 | av天堂久久9| 国产一区二区激情短视频| 国产在视频线精品| 最近最新免费中文字幕在线| 国产欧美日韩一区二区三区在线| 久久久久国产一级毛片高清牌| 亚洲视频免费观看视频| 热re99久久国产66热| 亚洲一码二码三码区别大吗| 久久久久久免费高清国产稀缺| 国产一区二区在线观看av| 久久精品熟女亚洲av麻豆精品| 淫妇啪啪啪对白视频| 免费高清在线观看日韩| av免费在线观看网站| 69精品国产乱码久久久| 日本欧美视频一区| 人人澡人人妻人| 国产一区二区激情短视频| 日日摸夜夜添夜夜添小说| 女人久久www免费人成看片| av国产精品久久久久影院| 亚洲精品美女久久久久99蜜臀| 精品一区二区三区av网在线观看 | 欧美中文综合在线视频| 亚洲成av片中文字幕在线观看| 亚洲欧美一区二区三区久久| 亚洲精品自拍成人| 国产深夜福利视频在线观看| 欧美另类亚洲清纯唯美| 国产欧美日韩精品亚洲av| 午夜福利影视在线免费观看| 这个男人来自地球电影免费观看| 亚洲专区中文字幕在线| 免费久久久久久久精品成人欧美视频| 久久久水蜜桃国产精品网| 超碰成人久久| 国产av又大| tube8黄色片| 正在播放国产对白刺激| 午夜福利在线免费观看网站| 老司机在亚洲福利影院| 操出白浆在线播放| 成年动漫av网址| 国精品久久久久久国模美| 男女免费视频国产| 老汉色∧v一级毛片| 国产区一区二久久| 亚洲,欧美精品.| 欧美乱码精品一区二区三区| 99riav亚洲国产免费| 亚洲伊人色综图| www.熟女人妻精品国产| a级片在线免费高清观看视频| 国产一区二区 视频在线| 久久中文字幕人妻熟女| 黄网站色视频无遮挡免费观看| 日本撒尿小便嘘嘘汇集6| 他把我摸到了高潮在线观看 | 一级片免费观看大全| 国产高清视频在线播放一区| 色综合欧美亚洲国产小说| 国产在线视频一区二区| 色老头精品视频在线观看| 别揉我奶头~嗯~啊~动态视频| 美女午夜性视频免费| 人人澡人人妻人| 黄频高清免费视频| 美女视频免费永久观看网站| 大片电影免费在线观看免费| 欧美激情极品国产一区二区三区| 亚洲色图av天堂| 黄色片一级片一级黄色片| 午夜福利一区二区在线看| 亚洲国产欧美网| 男女边摸边吃奶| 好男人电影高清在线观看| 国产精品久久电影中文字幕 | 久久亚洲真实| 狠狠精品人妻久久久久久综合| www.精华液| 国产精品一区二区在线观看99| 国产精品一区二区精品视频观看| 国产麻豆69| 亚洲第一青青草原| 欧美性长视频在线观看| 后天国语完整版免费观看| 精品一区二区三卡| 真人做人爱边吃奶动态| 母亲3免费完整高清在线观看| 久久久久久人人人人人| 夫妻午夜视频| 亚洲性夜色夜夜综合| 丰满饥渴人妻一区二区三| 国产成人欧美在线观看 | 国产极品粉嫩免费观看在线| 国产免费av片在线观看野外av| 亚洲中文日韩欧美视频| 亚洲人成电影观看| 欧美精品高潮呻吟av久久| 亚洲 欧美一区二区三区| 欧美精品一区二区大全| 欧美+亚洲+日韩+国产| 黑人猛操日本美女一级片| 大陆偷拍与自拍| 亚洲欧美激情在线| 亚洲第一欧美日韩一区二区三区 | 精品第一国产精品| 亚洲精品中文字幕一二三四区 | 大片电影免费在线观看免费| 亚洲av日韩精品久久久久久密| 女同久久另类99精品国产91| 国产单亲对白刺激| 黄色视频不卡| 亚洲精品成人av观看孕妇| 亚洲成国产人片在线观看| 在线天堂中文资源库| 下体分泌物呈黄色| 性少妇av在线| 99国产精品免费福利视频| 亚洲色图av天堂| 免费不卡黄色视频| 亚洲精品美女久久久久99蜜臀| 精品福利观看| 桃花免费在线播放| 久久久久精品人妻al黑| 一边摸一边抽搐一进一出视频| 一进一出抽搐动态| 久久中文看片网| 国产老妇伦熟女老妇高清| 99热国产这里只有精品6| av视频免费观看在线观看| 我要看黄色一级片免费的| 99热国产这里只有精品6| 宅男免费午夜| 色老头精品视频在线观看| 老司机午夜十八禁免费视频| 日韩欧美三级三区| 激情在线观看视频在线高清 | 亚洲自偷自拍图片 自拍| 免费观看a级毛片全部| 在线永久观看黄色视频| 超碰成人久久| 无人区码免费观看不卡 | 丰满少妇做爰视频| 欧美人与性动交α欧美精品济南到| 日韩欧美一区二区三区在线观看 |